| Literature DB >> 35454680 |
Babak Pakbin1,2, Wolfram Manuel Brück1, Samaneh Allahyari2, John W A Rossen3,4,5, Razzagh Mahmoudi2.
Abstract
BACKGROUND: Cronobacter sakazakii is a new emerging foodborne bacterial pathogen associated with severe lethal diseases such as meningitis, necrotizing enterocolitis, and septicemia in infants and neonates. Powdered infant formula milk (PIFM) has been recognized as one of the main transmission vehicles and contaminated sources of this pathogen. This study aimed to investigate the prevalence rate, genotypic and phenotypic antibiotic resistance profile, and clonal relatedness of C. sakazakii strains isolated from 364 PIFM samples collected from Tehran city, Iran.Entities:
Keywords: Cronobacter sakazakii; ERIC-PCR; antibiotic resistance; powdered infant formula milk
Year: 2022 PMID: 35454680 PMCID: PMC9029396 DOI: 10.3390/foods11081093
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Prevalence rates of different antibiotic resistance phenotypes in C. sakazakii strains isolated from PIFM samples. * indicates significant differences (p > 0.05). NAL, nalidixic acid; FOX, cefoxitin; AZM, azithromycin; SPT, streptomycin; AMC, amoxicillin-clavulanic acid; IPM, imipenem; KAN, kanamycin; AMX, amoxicillin; NOR, norfloxacin; AMP, ampicillin; TET, tetracycline; FEP, cefepime; GEN, gentamicin; CST, colistin; CHL, chloramphenicol; ERY, erythromycin; CTR, ceftriaxone and CIP, ciprofloxacin.
Multidrug resistance class patterns of C. sakazakii strains isolated from PIFM samples.
| No. Classes of Antibiotics | Multidrug Resistance Patterns a (No. Isolates in Each Pattern) | No. Total Isolates (%) ( |
|---|---|---|
| Two | βLs-QNs ( | 1 (4) |
| Three | βLs-QNs-MLs ( | 11 (44) |
| βLs-PNs-MLs ( | ||
| Four | βLs-AGs-LPs-MLs ( | 3 (12) |
| βLs-PNs-MLs-QNs ( | ||
| βLs-AGs-LPs-QNs ( | ||
| Five | βLs-QNs-MLs-AGs-TCs ( | 2 (8) |
| βLs-QNs-MLs-AGs-LPs ( | ||
| Six | βLs-QNs-AGs-LPs-MLs-PNs ( | 8 (32) |
a βLs, β-lactams; AGs, aminoglycosides; LPs, lipopeptides; TCs, tetracyclines; PNs, phenicols; QNs, quinolones and fluoroquinolones; MLs, macrolides.
Figure 2Prevalence rates of ESBLs genes in C. sakazakii strains isolated from PIFM samples. * indicates significant differences (p > 0.05). blaSHV, blaSHV; blaOXA, blaOXA; blaTEM, blaTEM; CTXM1, blaCTX-M-1; CTXM2, blaCTX-M-2; CTXM8, blaCTX-M-8 and CTXM9, blaCTX-M-9.
Figure 3UPGMA dendrogram of C. sakazakii isolates from PIFM samples indicating the Dice coefficient based on ERIC-PCR analysis.
Resistance phenotype, genotype and ERIC-PCR types in C. sakazakii strains isolated from PIFM samples.
| No. | Isolate | Resistance Phenotype a | Resistance Genotype b | ERIC-PCR Type |
|---|---|---|---|---|
| 1 | CS1 | NAL, FOX, AZM, AMC, IPM, KAN, AMX, AMP, TET, FEP, GEN, ERY | C1, S, O, T | E1 |
| 2 | CS2 | NAL, FOX, AMC, IPM, KAN, AMX, AMP, FEP, ERY, CST | C1, C2, C9 | E1 |
| 3 | CS3 | FOX, AZM, AMC, IPM, KAN, AMX, AMP, FEP, ERY, CST | C1, S, O | E1 |
| 4 | CS4 | FOX, AMC, IPM, KAN, NOR, AMP, FEP, CST | C1 | E1 |
| 5 | CS5 | NAL, FOX, AMC, AMX, AMP, FEP, ERY, CTR | C1 | E1 |
| 6 | CS6 | FOX, AMC, AMX, AMP, FEP, CHL, ERY, CTR | C1 | E6 |
| 7 | CS7 | FOX, SPT, AMC, AMX, AMP, FEP, CST, CHL, ERY, CTR, CIP | C1, S, O, T | E2 |
| 8 | CS8 | FOX, AMC, IPM, AMX, AMP, FEP, ERY, CTR, CIP | C1 | E6 |
| 9 | CS9 | FOX, AMC, AMX, AMP, FEP, CHL, ERY, CTR | C1 | E7 |
| 10 | CS10 | SPT, AMC, AMX, AMP, FEP, CST, CHL, ERY, CTR, CIP | C1, C8, C9 | E8 |
| 11 | CS11 | FOX, AMC, IPM, AMX, AMP, FEP, ERY, CTR, CIP | C1, C2, C9 | E8 |
| 12 | CS12 | FOX, SPT, AMC, AMX, AMP, CST, CHL, ERY, CTR, CIP | C1, S, O | E3 |
| 13 | CS13 | FOX, AMC, IPM, AMX, AMP, FEP, ERY, CIP | C1 | E5 |
| 14 | CS14 | FOX, AMC, AMX, AMP, FEP, CHL, ERY, CIP | C1 | E3 |
| 15 | CS15 | FOX, AMC, IPM, AMX, AMP, FEP, CST, CHL, ERY, CTR, CIP | C1, C8, C9 | E3 |
| 16 | CS16 | NAL, FOX, AMC, AMX, AMP, FEP, ERY, CTR | C1 | E4 |
| 17 | CS17 | FOX, AMC, AMX, FEP, CHL, ERY, CTR, | C1 | E4 |
| 18 | CS18 | FOX, SPT, AMC, AMX, AMP, FEP, CST, CHL, ERY, CTR, CIP | C1, C2, C9 | E4 |
| 19 | CS19 | IPM, AMX, AMP, FEP, CTR, CIP | C1 | E4 |
| 20 | CS20 | FOX, AMC, AMX, AMP, FEP, CHL, ERY, CTR | C1, S, O | E3 |
| 21 | CS21 | FOX, SPT, AMC, AMX, AMP, CST, CHL, ERY, CTR, CIP | C1, S, O, T | E3 |
| 22 | CS22 | FOX, AMC, IPM, AMX, AMP, FEP, ERY, CTR, CIP | C8 | E4 |
| 23 | CS23 | FOX, SPT, AMC, AMX, AMP, FEP, CST, CHL, ERY, CTR, CIP | C1, C2, C9 | E4 |
| 24 | CS24 | FOX, AMC, IPM, AMX, AMP, FEP, ERY, CTR, CIP | C1, C2, C9 | E4 |
| 25 | CS25 | FOX, SPT, AMC, AMX, AMP, FEP, CST, CHL, ERY, CTR, CIP | C1, O, C9 | E4 |
a NAL, nalidixic acid; FOX, cefoxitin; AZM, azithromycin; SPT, streptomycin; AMC, amoxicillin-clavulanic acid; IPM, imipenem; KAN, kanamycin; AMX, amoxicillin; NOR, norfloxacin; AMP, ampicillin; TET, tetracycline; FEP, cefepime; GEN, gentamicin; CST, colistin; CHL, chloramphenicol; ERY, erythromycin; CTR, ceftriaxone; CIP, ciprofloxacin. b S, blaSHV; O, blaOXA; T, blaTEM; C1, blaCTX-M-1; C2, blaCTX-M-2; C8, blaCTX-M-8; C9, blaCTX-M-9.